P3 Health Partners Inc (PIII)

Currency in USD
3.7550
+0.1450(+4.02%)
Closed·
3.75000.0000(0.00%)
·
PIII is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.66003.8000
52 wk Range
3.500014.5000
Key Statistics
Prev. Close
3.61
Open
3.66
Day's Range
3.66-3.8
52 wk Range
3.5-14.5
Volume
7.51K
Average Volume (3m)
7.26K
1-Year Change
-61.27%
Book Value / Share
-5.72
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PIII Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
10.2500
Upside
+172.97%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

P3 Health Partners Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

P3 Health Partners Company Profile

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. The company operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.

P3 Health Partners Inc Earnings Call Summary for Q3/2025

  • P3 Health Partners reported Q3 capitated revenue of $341.6 million with an adjusted EBITDA loss of $45.9 million, despite achieving over $100 million in year-over-year EBITDA improvement.
  • The company revised its full-year adjusted EBITDA guidance to between -$110 million and -$95 million, with stock falling 8.14% to $7 following the announcement.
  • Management identified EBITDA expansion opportunities of $120-$170 million for 2026 and expects to achieve 'meaningful profitability' next year.
  • Strategic initiatives include a joint venture adding 13,000 ACO members and plans to expand Medicare Advantage pipeline by 25,000 lives in 2026.
  • CEO Eric Kaufman emphasized 'disciplined execution' and network alignment as key priorities, while the company ended Q3 with a cash position of $37.7 million.
Last Updated: 14/11/2025, 14:02
Read Full Transcript

Compare PIII to Peers and Sector

Metrics to compare
PIII
Peers
Sector
Relationship
P/E Ratio
−0.2x8.5x−0.6x
PEG Ratio
0.000.050.00
Price/Book
−1.4x1.9x2.6x
Price / LTM Sales
0.0x0.8x3.2x
Upside (Analyst Target)
183.9%31.8%41.8%
Fair Value Upside
Unlock21.7%5.1%Unlock

Analyst Ratings

1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 10.2500
(+172.97% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Lake Street Capital Markets
Buy12.50+232.89%20.00Maintain17/11/2025
Lake Street Capital Markets
Buy20.00+432.62%-New Coverage28/08/2025
TD Cowen
Hold8.00+113.05%12.50Maintain28/05/2025
Lake Street Capital Markets
Buy20.00+432.62%50.00Maintain21/04/2025
BTIG
Hold---Maintain28/03/2025

Earnings

Latest Release
Nov 13, 2025
EPS / Forecast
-9.67 / -0.092
Revenue / Forecast
345.25M / 342.91M
EPS Revisions
Last 90 days

People Also Watch

44.01
AFJK
+37.49%
0.43
ZSPC
-4.45%
0.9279
AUID
+0.62%
0.0798
VSME
-10.34%
0.047
VIVK
-24.39%

FAQ

What Is the P3 Health Partners (PIII) Share Price Today?

The live P3 Health Partners share price today is 3.7550

What Stock Exchange Does P3 Health Partners (PIII) Trade On?

P3 Health Partners is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for P3 Health Partners?

The stock symbol (also called a 'ticker') for P3 Health Partners is "PIII."

What Is the Current P3 Health Partners Market Cap?

As of today, P3 Health Partners market capitalisation is 27.06M.

What Is P3 Health Partners's (PIII) Earnings Per Share (TTM)?

The P3 Health Partners EPS is currently -42.95 (Trailing Twelve Months).

Is PIII a Buy or Sell From a Technical Analyst Perspective?

Based on today's P3 Health Partners moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has P3 Health Partners Stock Split?

P3 Health Partners has split 1 times. (See the PIII stock split history page for full effective split date and price information.)

How Many Employees Does P3 Health Partners Have?

P3 Health Partners has 360 employees.

What is the current trading status of P3 Health Partners (PIII)?

As of 24 Dec 2025, P3 Health Partners (PIII) is trading at a price of 3.7550, with a previous close of 3.6100. The stock has fluctuated within a day range of 3.6600 to 3.8000, while its 52-week range spans from 3.5000 to 14.5000.

What Is P3 Health Partners (PIII) Price Target According to Analysts?

The average 12-month price target for P3 Health Partners is USD10.25, with a high estimate of USD12.5 and a low estimate of USD8. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +172.97% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.